Alexandria Real Estate Equities (ARE) Buy,…

Alexandria Real Estate Equities (ARE)

Alexandria Real Estate Equities (ARE) is covered by Stockchase stock experts. Read their latest opinions, ratings and top picks below.

43.87

-1.64 (3.60%)

as of Oct 12, 2026, 4:54:45 pm Market Open.

21 watching

DON'T BUY

Lost 50% last year. Has been suffering from unit tenant demand for a while, partially from a weaker IPO market. Last year, they slashed their dividend by 45% at nearly 6%.

Wealthica Track your Stocks in your Watch List

DON'T BUY

The largest US office REIT. Used to own it, still likes it alot for owning specialized spaces, like labs for biotechs. But this niche has problems, lacking IPOs and new companies. Is down 20% YTD.

BUY

Admires the management, but he doesn't like commercial office space now, but ARE's tenants are American biotech and life science companies, which carry the costs of. A lot of value here.

TOP PICK

The only REIT in health sciences, and is benefiting from demand to treat and cure COVID-19 and other diseases. Though considered an office REIT, she notes that many of its tenants cannot work from home. Rent collection is impressive at 99%, because life sciences are deemed essential. It leased 1 million sq. feet in Q2, consistent with prior quarters with rents 15% higher. Likes its assets, and it's a niche way to play this sector. (Analysts’ price target is $181.56)

PAST TOP PICK

(A Top Pick Dec 05/18, Up 33%) When he called it, ARE wasn't cheap. They hold life sciences properties, which is solid and lucrative (fuelled by R&D spending). They can raise rents by 20-30% annually with these companies, which means strong cash flow growth.

PAST TOP PICK

(A Top Pick Aug 16/18, Up 24%) One of the best capital compounders out there. They build life sciences buildings on campuses across the US. Biotech companies co-locate on these campuses, creating great opportunities. The fundamentals remain positive and he continues to hold it.

PAST TOP PICK

(A Top Pick Dec 05/18, Up 16%) They are a stellar company with a stellar management team. They are the dominant player of campuses to life sciences companies. It is important for these companies to be together to share ideas in an ecosystem. They have a free cash flow growth of north of 10%. He sees the company growing with their valuation. It is still a compelling investment opportunity.

TOP PICK

The entry point is great right now. They look to double their revenues by 2022 from $900 million today. They have a great balance sheet and management team. They hold assets in all the major US campuses. They are the curators of new biotech and big pharma real estate start-ups on and near these campuses. When a lease comes due, they can raise rents 30% or more. Yield 3%. (Analysts’ price target is $138.25)

PAST TOP PICK

(A Top Pick Aug 16/18, Down 3%) They hold assets in all the major US campuses. They are the curators of new biotech and big pharma real estate start-ups on and near these campuses. When a lease comes due, they can raise rents 30% or more.

TOP PICK

They specialize in technology and life-sciences clusters. Their tenants will be repatriation cash, so ARE's partnership with these tenants will create value and rent growth. (2.9% dividend yield)

Showing 1 to 10 of 10 entries

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Brian Madden

First Avenue Investment Counsel

Jamie Murray

Murray Wealth Group

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Alexandria Real Estate Equities (ARE) Frequently Asked Questions

What is Alexandria Real Estate Equities stock symbol?

Alexandria Real Estate Equities is a American stock, trading under the symbol ARE (previously ARE-N on Stockchase) on the New York Stock Exchange (ARE). It is usually referred to as NYSE:ARE or ARE

Is Alexandria Real Estate Equities a buy or a sell?

In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on ARE (previously ARE-N on Stockchase). 0 analysts recommended to BUY and 1 analyst recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for Alexandria Real Estate Equities.

Is Alexandria Real Estate Equities a good investment or a top pick?

Alexandria Real Estate Equities was recommended as a Top Pick by Jim Cramer - Mad Money on 2026-01-05. Read the latest stock experts ratings for Alexandria Real Estate Equities.

Why is Alexandria Real Estate Equities stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Alexandria Real Estate Equities.

Is Alexandria Real Estate Equities worth watching?

Alexandria Real Estate Equities is followed by 21 investors on Stockchase and is a trending stock that is worth watching.

What is Alexandria Real Estate Equities stock price?

On 2026-10-12, Alexandria Real Estate Equities (ARE) stock closed at a price of $43.87.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Halloween Sale

Alexandria Real Estate Equities (ARE)